This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coffey, M. J.
Right arrow Articles by Ross, L. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coffey, M. J.
Right arrow Articles by Ross, L. F.
Related Collections
Right arrow Asthma
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
PEDIATRICS Vol. 113 No. 1 January 2004, pp. 87-94

Ethical Assessment of Clinical Asthma Trials Including Children Subjects

M. Justin Coffey, AB*, Benjamin Wilfond, MD{ddagger},§ and Lainie Friedman Ross, MD, PhD||,¶

* Pritzker School of Medicine
|| Department of Pediatrics
MacLean Center for Clinical Medical Ethics, University of Chicago, Chicago, Illinois
{ddagger} Bioethics Research Section, Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD
§ Genetics Section, Department of Clinical Bioethics, Warren G. Magnuson Clinical Center, Bethesda, Maryland

Background. The inclusion of children with asthma in clinical asthma trials is increasing, including their participation in placebo-controlled trials (PCTs). The objectives of this study are to assess whether children with asthma have been harmed by their participation in PCTs.

Methods. Seventy clinical asthma trials involving children published between January 1998 and December 2001 that involved distinct US research populations were identified. Studies were reviewed to determine whether all subjects with more than mild asthma received daily antiinflammatory medication as recommended by national guidelines. Sixty-two clinical asthma trials included data about subject withdrawal and were analyzed for the frequency of asthma exacerbations.

Results. Forty-five studies were designed as PCTs and did not require that all subjects with more than mild asthma receive antiinflammatory medications. Of 24 953 subjects, 4653 (19%) for whom data are available withdrew from research, and 1247 subjects (9.4%) withdrew from PCTs due to asthma exacerbations compared with 358 subjects (3.1%) in other trials. In PCTs, subjects withdrew more frequently from the placebo arms than the active-treatment arms and did so more frequently because of an asthma exacerbation (667 or 15% vs 580 or 6.5%). Fifty-two studies enrolled both children and adults, although only 1 performed subset analysis of the children.

Conclusions. Subjects enrolled in PCTs of asthma have been exposed to unnecessary risks and harms. Clinical asthma trials involving children and adults do not benefit children as a class because they rarely provide subset analysis of children subjects.

Key Words: asthma • clinical trials • placebo-controlled trials • children • ethics

Abbreviations: NHLBI, National Heart, Lung, and Blood Institute • ICS, inhaled corticosteroids • PCT, placebo-controlled trial • IRB, Institutional Review Board • CAMP, Childhood Asthma Management Program

Received for publication Dec 9, 2002; Accepted Mar 14, 2003.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 CLIN PEDIATRHome page
M. J. Welch
Nebulization Therapy for Asthma: A Practical Guide for the Busy Pediatrician
Clinical Pediatrics, October 1, 2008; 47(8): 744 - 756.
[PDF]

Home page
 J Law Med EthicsHome page
K. C. Glass and A. Binik
Rethinking risk in pediatric research.
J. Law Med. Ethics, September 1, 2008; 36(3): 567 - 576.
[PDF]

Home page
 Qualitative InquiryHome page
C.K. Gunsalus, E. M. Bruner, N. C. Burbules, L. Dash, M. Finkin, J. P. Goldberg, W. T. Greenough, G. A. Miller, M. G. Pratt, M. Iriye, et al.
The Illinois White Paper: Improving the System for Protecting Human Subjects: Counteracting IRB "Mission Creep"
Qualitative Inquiry, July 1, 2007; 13(5): 617 - 649.
[Abstract] [PDF]

Home page
 ChestHome page
H. Bisgaard, P. Le Roux, D. Bjamer, A. Dymek, J. H. Vermeulen, and C. Hultquist
Budesonide/Formoterol Maintenance Plus Reliever Therapy: A New Strategy in Pediatric Asthma
Chest, December 1, 2006; 130(6): 1733 - 1743.
[Abstract] [Full Text] [PDF]